tradingkey.logo

NewGenIvf Group Ltd

NIVF
1.000USD
0.0000.00%
Fechamento 02/06, 16:00ETCotações atrasadas em 15 min
143.51KValor de mercado
0.00P/L TTM

NewGenIvf Group Ltd

1.000
0.0000.00%

Mais detalhes de NewGenIvf Group Ltd Empresa

NewGenIvf Group Limited is a comprehensive fertility services provider in Asia helping couples and individuals obtain access to fertility treatments. It specializes in in-vitro fertilization (IVF) treatment and surrogacy and ancillary caring services. Its fertility treatments, such as IVF, intracytoplasmic sperm injection, intrauterine insemination, egg freezing, embryo transfer, gender selection, semen analysis, hysteroscopy, fertility checkups, testicular sperm aspiration and percutaneous epididymal sperm aspiration. Its clinics are in Thailand, Cambodia, and Kyrgyzstan, and present a full suite of services for its patients, including comprehensive infertility and assisted reproductive technology treatments, egg and sperm donation, and surrogacy, in the appropriate jurisdictions. It has acquired cytometry technology and assets including 18 fully constructed cell-sorting and dispensing systems, eight partially constructed units and six patents related to advanced microfluidic systems.

Informações de NewGenIvf Group Ltd

Código da empresaNIVF
Nome da EmpresaNewGenIvf Group Ltd
Data de listagemFeb 15, 2022
CEOWing Fung (Siu)
Número de funcionários76
Tipo de títulosOrdinary Share
Fim do ano fiscalFeb 15
Endereço13/F, Ps Tower, Sukhumvit 21 Rd (Asoke)
CidadeBANGKOK
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísThailand
Código postal- -
Telefone
Sitehttps://newgenivf.com/
Código da empresaNIVF
Data de listagemFeb 15, 2022
CEOWing Fung (Siu)

Executivos da empresa NewGenIvf Group Ltd

Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Siu (Alfred) Wing Fung
Mr. Siu (Alfred) Wing Fung
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
Ms. Fong (Tina) Hei Yue
Ms. Fong (Tina) Hei Yue
Chief Marketing Officer, Director
Chief Marketing Officer, Director
--
--
Mr. Au (Jefferson) Hok Man
Mr. Au (Jefferson) Hok Man
Independent Director
Independent Director
--
--
Ms. Wan Chan Ann Chi
Ms. Wan Chan Ann Chi
Independent Director
Independent Director
--
--
Mr. Wa Tam Chun
Mr. Wa Tam Chun
Independent Director
Independent Director
--
--
Mr. Fai Chung Ho
Mr. Fai Chung Ho
Chief Financial Officer
Chief Financial Officer
--
--
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Siu (Alfred) Wing Fung
Mr. Siu (Alfred) Wing Fung
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
Ms. Fong (Tina) Hei Yue
Ms. Fong (Tina) Hei Yue
Chief Marketing Officer, Director
Chief Marketing Officer, Director
--
--
Mr. Au (Jefferson) Hok Man
Mr. Au (Jefferson) Hok Man
Independent Director
Independent Director
--
--
Ms. Wan Chan Ann Chi
Ms. Wan Chan Ann Chi
Independent Director
Independent Director
--
--
Mr. Wa Tam Chun
Mr. Wa Tam Chun
Independent Director
Independent Director
--
--
Mr. Fai Chung Ho
Mr. Fai Chung Ho
Chief Financial Officer
Chief Financial Officer
--
--

Detalhamento da receita

Moeda: USDAtualizado em: ter, 6 de jan
Moeda: USDAtualizado em: ter, 6 de jan
FY2024
FY2024Q4
FY2024Q3
FY2023
Por EmpresaUSD
Nome
Receita
Proporção
IVF treatment service
5.43M
0.00%
Surrogacy, ancillary caring and other services
0.00
0.00%
Por RegiãoUSD
Nome
Receita
Proporção
Kyrgyzstan
2.66M
48.89%
Thailand
2.18M
40.04%
Cambodia
601.53K
11.07%
HK SAR
0.00
0.00%
Por Empresa
Por Região
Por EmpresaUSD
Nome
Receita
Proporção
IVF treatment service
5.43M
0.00%
Surrogacy, ancillary caring and other services
0.00
0.00%

Distribuição de ações

Atualizado em: seg, 2 de fev
Atualizado em: seg, 2 de fev
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
UBS Financial Services, Inc.
0.13%
JAK Opportunities VI LLC
0.10%
Outro
99.77%
Investidores
Investidores
Proporção
UBS Financial Services, Inc.
0.13%
JAK Opportunities VI LLC
0.10%
Outro
99.77%
Tipos de investidores
Investidores
Proporção
Investment Advisor
0.14%
Corporation
0.10%
Individual Investor
0.03%
Outro
99.73%

Participação acionária institucional

Atualizado em: qui, 1 de jan
Atualizado em: qui, 1 de jan
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q4
34
1.53K
0.16%
+1.18K
2025Q3
39
5.79K
0.20%
+1.91K
2025Q2
46
23.90K
1.31%
+20.74K
2025Q1
47
53.83K
2.05%
+29.38K
2024Q4
57
480.38K
3.57%
+160.77K
2024Q3
54
388.28K
4.20%
+63.85K
2024Q2
55
392.14K
4.96%
+40.32K
2024Q1
48
150.75K
80.91%
-221.01K
2023Q4
49
198.33K
101.36%
-231.83K
2023Q3
47
276.28K
99.62%
-143.70K
Ver Mais

Atividade dos acionistas

Nome
Ações detidas
Proporção
Variação
Var. %
Data
JAK Opportunities VI LLC
2.92K
0.22%
+2.92K
--
Apr 20, 2025
ATW Spac Management LLC
225.00
0.02%
+225.00
--
Oct 04, 2024
White Lion Capital LLC
140.00
0.01%
+140.00
--
Nov 21, 2024
SBI Securities Co., Ltd.
62.00
0%
+62.00
--
Sep 30, 2025
BofA Global Research (US)
2.00
0%
+2.00
--
Sep 30, 2025
RiverNorth Capital Management LLC
--
0%
-18.00
-100.00%
Sep 30, 2024
MMCAP Asset Management
--
0%
-10.00
-100.00%
Jun 30, 2025
Ver Mais

ETFs Relacionados

Nome
Proporção
Sem dados

Dividendo

Um total de 0.00 USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados

Desdobramento de ações

Data
Data ex-dividendo
Tipo
Proporção
Jan 20, 2026
Merger
3→1
Nov 11, 2025
Merger
5→1
Jul 28, 2025
Merger
5→1
Apr 16, 2025
Merger
10→1
Jan 31, 2025
Merger
20→1
Jan 31, 2025
Merger
20→1
Data
Data ex-dividendo
Tipo
Proporção
Jan 20, 2026
Merger
3→1
Nov 11, 2025
Merger
5→1
Jul 28, 2025
Merger
5→1
Apr 16, 2025
Merger
10→1
Jan 31, 2025
Merger
20→1
Jan 31, 2025
Merger
20→1
Jan 31, 2025
Merger
20→1
Jan 31, 2025
Merger
20→1
KeyAI